Sleep Apnea Device Market Research Report - Global Forecast till 2027

Global Sleep Apnea Device Market: Information By Type (Diagnostic Devices and Therapeutic Devices), By End User (Home Care Settings and Sleep Laboratories & Hospitals) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1529-CR | March 2021 | Region: Global | 159 pages

Please note that the assessment period of report has been updated from 2018-2022 to 2020-2027. Cordially fill the sample form for updated data.

Synopsis


Global Sleep Apnea Device Market is expected to register a CAGR of 6.52% during the assessment period of 2020 to 2027, to reach USD 7,683.72 Million by 2027.


Market Dynamics


Technological advancements in sleep apnea devices are driving the growth of this market. Technological advancements enable the manufacturers to develop the product, providing patient safety, product adaptation, and treatment comfort. Key players are developing products that are more comfortable for the patients. For instance, Philips Respironics launched ‘DreamStation Go,’ a travel-friendly Positive Airway Pressure (PAP) device for the active patient population in April 2017. DreamStation Go is an ultra-portable Positive Airway Pressure (PAP) therapy system designed for frequent travelers. Patients can rely on its unique blend of packability, connectivity, and powerful, convenient features. Similarly, in October 2017, Respicardia announced the approval of Remed System from the US FDA for the treatment of moderate-to-severe central sleep apnea. The Red System monitors the patient’s respiratory signals during sleep and stimulates the nerve to move the diaphragm and restore normal breathing. These technologically advanced devices are more acceptable to patients with sleep apnea, and this trend is expected to continue during the forecast period.


Global Sleep Apnea Device Market, By Type 2019 (%)
Sleep Apnea Device Market


Source: MRFR Analysis


Segmentation


Global Sleep Apnea Device Market is segmented based on Type and End User.


The global sleep apnea device market based on type has been segmented into diagnostic and therapeutic devices. Diagnostic devices are further classified into polysomnography devices, home sleep testing devices, pulse oximeters, sleep screening devices. Polysomnography devices dominated the market in 2019. The high prevalence of sleep apnea and the growing geriatric population which is prone to respiratory disorders, are the key factors creating a huge demand for diagnostic devices. As per the report presented by ResMed at the American Thoracic Society (ATS) 2018 International Conference, OSA afflicted more than 936 million people worldwide in 2018, which is almost 836% more than the affected population 2007. Thus, rising number of people suffering from this disorder has resulted in a growing demand for sleep apnea diagnostic devices.


Polysomnography devices are used to monitor sleep stages and cycles to identify when sleep patterns are disrupted and why. Increasing number of product development and launch is also propelling the growth of this segment. For instance, in September 2020, Nihon Kohden a leading manufacturer, developer and distributor of medical electronic equipment, announced the launch of Polysmith 12 polysomnography software. Version 12 of the Polysmith software includes more than 40 market-driven features that offer sleep specialists improved workflow, analysis and outcomes. Owining to various factors which are propelling the growth of polysomnography devices segment.


Western Europe Sleep Apnea Device Market Share, By Country, 2019 (%)
Sleep Apnea Device Market


Source: MRFR Analysis


Regional Analysis


Global Sleep Apnea Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market in 2019 and the trend is likely to continue during the assessment period. This is attributed to s rising prevalence of Obstructive Sleep Apnea (OSA), increasing patient adherence for positive airway pressure devices, and medical coverage for sleep apnea devices.


The European sleep apnea device market has been divided into Western Europe and Eastern Europe. The Western Europe sleep apnea device Market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe would follow the Americas, in terms of value, during the forecast period. The growing elderly population base prone to suffer from sleeping disorders is another chief reason escalating the business growth.


TAsia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to witness the highest market growth potential over the forecast period due to increasing per capita health spending, the developing healthcare sector in China, India, and Australia, growing demand for sleep apnea device such as continuous positive airway pressure (CPAP) machine used for the diagnosis of sleep disorders, and the rising patient population suffering from sleep apnea.


The Middle East & Africa sleep apnea device market is segmented into the Middle East and Africa. The increasing number of companies and subsidiaries in the region providing sleep apnea devices, rising prevalence of OSA, and ever-increasing demand for the treatment of sleep disorders in this region are anticipated to drive the market growth in this region.


Key Players


The Prominent Players in the Global Sleep Apnea Device Market are Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US).


Some of the key strategies followed by players operating in the global sleep apnea device market were FDA approvals, joint ventures, acquisitions, expansions, and collaborations.



  • In April 2020, Cadwell Industries, Inc. re-introduced the ApneaTrak home sleep apnea testing (HSAT) device, with three models, to meet multiple levels of clinical needs to help diagnose sleep apnea and to test the efficacy of treatments.


Market Segmentation


Global Sleep Apnea Device Market, By Type



  • Diagnostic Devices

  • Therapeutic Devices


Global Sleep Apnea Device Market, By Diagnostic Device Type



  • Polysomnography Devices

  • Home Sleep Testing Devices

  • Pulse Oximeters

  • Sleep Screening Devices


Global Sleep Apnea Device Market, By Therapeutic Device Type



  • Positive Airway Pressure Devices (PAPD)

  • Facial Interfaces

  • Accessories

  • Oral Appliances

  • Adaptive Servo-Ventilators

  • Surgical Devices


Global Sleep Apnea Device Market, By PAPD Type



  • Automatic Positive Airway Pressure Devices

  • Continuous Positive Airway Pressure Devices

  • Bilevel Positive Airway Pressure Devices


Global Sleep Apnea Device Market, By Facial Interface Type



  • Full-Face Masks

  • Nasal Pillow Masks

  • Nasal Masks


Global Sleep Apnea Device Market, By Oral Application Type



  • Mandibular Advancement Devices

  • Tongue-Retaining Devices


Global Sleep Apnea Device Market, By End-user



  • Hospital/clinical laboratories

  • Diagnostics laboratories

  • Others


Global Sleep Apnea Device Market, By Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Impact of COVID-19 on the Sleep Apnea Device Market

  • Mega Trends in the Market

  • Investment Opportunities

  • Pricing Analysis


Intended Audience



  • Hospitals & Clinics

  • Pharmaceutical companies

  • Medical device companies

  • Academic institutes



Report Scope:
Report Attribute/Metric Details
  Market Size   7,683.72 Million
  CAGR   6.52%
  Base Year   2020
  Forecast Period   2027
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors and Trends
  Segments Covered   Type and End User
  Geographies Covered   North America, Europe, Asia-Pacific and Rest of the World (RoW)
  Key Vendors   Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US)
  Key Market Opportunities   Product development and launch
  Key Market Drivers

  • Technological advancements
  • Product adaptation


  • Frequently Asked Questions (FAQ) :


    The valuation of the global sleep apnea device market is expected to reach USD 6.9 BN by the end of 2022.

    The valuation of the global sleep apnea device market had settled at USD 4.7 BN in 2016.

    Sleep Apnea Device Market is projected grow at 7.5% CAGR during the assessment period (2016-2022).

    Increasing government funding to support R&D and rising preference for using devices to treat sleep apnea instead of surgeries and medications are the major tailwinds pushing the growth of the global sleep apnea devices market.

    North America holds the largest share in the global sleep apnea devices market, followed by Europe and the Asia Pacific, respectively.

    Koninklijke Philips N.V. (Netherlands), ResMed (US), Fisher & Paykel Healthcare Limited (New Zealand), Invacare Corporation (US), GE Healthcare (US), BMC Medical Co, Ltd (China), ImThera Medical Inc. (US), Braebon Medical Corporation (Canada), Curative Medical (US), and Cadwell Industries, Inc.(US), are some of the major players operating in the sleep apnea devices market.